Will Spooren is section head of behavioral pharmacology and preclinical imaging at Hoffman-La Roche and coordinator of EU-AIMS.
Will Spooren
Head of behavioral pharmacology and preclinical imaging
F. Hoffmann-La Roche
From this contributor
Questions for Will Spooren: Paving a path to autism drugs
A European initiative that aims to provide a framework for clinical trials in autism has developed tools to track treatment responses.
Questions for Will Spooren: Paving a path to autism drugs
Explore more from The Transmitter
Scaling up n-of-1 trials; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 16 November.
Scaling up n-of-1 trials; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 16 November.
This paper changed my life: The salience network makes its mark
Vinod Menon’s 2008 PNAS paper found that activity in the salience network allows the brain to switch between different areas that control cognitive processing. The work drove Uddin to focus her research on large-scale brain networks and interactions among them.
This paper changed my life: The salience network makes its mark
Vinod Menon’s 2008 PNAS paper found that activity in the salience network allows the brain to switch between different areas that control cognitive processing. The work drove Uddin to focus her research on large-scale brain networks and interactions among them.
How does the developing brain make so many different types of neurons?
Oliver Hobert describes how analyzing patterns of gene expression and connectivity in closely and more distantly related species of nematodes sheds light on the structural and functional organization of the nervous system.
How does the developing brain make so many different types of neurons?
Oliver Hobert describes how analyzing patterns of gene expression and connectivity in closely and more distantly related species of nematodes sheds light on the structural and functional organization of the nervous system.